ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Enrique
Aranda Aguilar
Publicaciones en las que colabora con Enrique Aranda Aguilar (8)
2023
-
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 2, pp. 379-388
2020
2019
-
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)
Scientific Reports
-
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
Scientific Reports, Vol. 9, Núm. 1
-
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy
Annals of Oncology, Vol. 30, Núm. 3, pp. 439-446
2017
-
Optimization of RAS/BRAF mutational analysis confirms improvement in patient selection for clinical benefit to anti-EGFR treatment in metastatic colorectal cancer
Molecular Cancer Therapeutics, Vol. 16, Núm. 9, pp. 1999-2007
2015
-
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 972-981
2011
-
Treatment recommendations for metastatic colorectal cancer
Clinical and Translational Oncology, Vol. 13, Núm. 3, pp. 162-178